Produkty 67034-83-7

CAS 67034-83-7 występuje w naszej ofercie pod nazwami: Dehydroepiandrosterone (Dhea) (16,16-D2, 97%), >95% (HPLC), Dehydroepiandrosterone-16,16-d2, 97 atom % D, min 98% Chemical Purity, Dehydroepiandrosterone-d2, DHEA–16,16–d2. Oferty producentów: TRC, CDN, TargetMol, GLPBio. Dostępne opakowania: 12,5mg, 1mg, 2,5mg, 0,1g, 0,05g, 10mg, 5mg.

Dehydroepiandrosterone (Dhea) (16,16-D2, 97%), >95% (HPLC)
TRC
  • opakowanie: 12,5mg, 1mg, 2,5mg
  • Warianty: 3
Zobacz produkt
Dehydroepiandrosterone-16,16-d2, 97 atom % D, min 98% Chemical Purity
CDN
  • opakowanie: 0,1g, 0,05g
  • Warianty: 2
Zobacz produkt
Dehydroepiandrosterone-d2
TargetMol
  • opakowanie: 1mg
  • Warianty: 1
od 624,84
Zobacz produkt
DHEA–16,16–d2
GLPBio
  • opakowanie: 1mg, 10mg, 5mg
  • Warianty: 3
od 774,90
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one (CAS 67034-83-7) to związek chemiczny o wzorze sumarycznym C19H28O2 i masie molowej 288.4 g/mol. Nazwa systematyczna IUPAC: 3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one. InChIKey: FMGSKLZLMKYGDP-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H28O2
Masa molowa288.4 g/mol
Nazwa IUPAC3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one
InChIKeyFMGSKLZLMKYGDP-UHFFFAOYSA-N
SMILESCC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 3-Hydroxyandrost-5-en-17-one, ITdU, Spectrum_000661, SpecPlus_000094, Spectrum2_000359, Spectrum3_000116, Spectrum4_001395, Spectrum5_000130, KBioGR_001750, KBioSS_001141
Powiązane formy tego związku
(3R,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(3S,8R,9S,10R,13R,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(3S,8R,9S,10R,13S,14S)-2,2,3,4,4-pentadeuterio-3-hydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-one C19H28O2
(3S,8R,9S,10R,13S,14S)-2,2,3,4,4,6-hexadeuterio-3-hydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-one C19H28O2
Izomery (ten sam wzór sumaryczny)
(3S,5S,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dione C19H28O2
(4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaenoic acid C19H28O2
(3R,5R,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(3R,5S,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2
(8R,9S,10R,13S,14S,17S)-13-ethyl-17-hydroxy-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one C19H28O2
(3S,5R,8S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one C19H28O2